Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study

Magnetic resonance imaging (MRI) targeted biopsy (TBx) of the prostate demonstrated to improve detection rate (DR) of clinically significant prostate cancer (csPCa) in biopsy-naive patients achieving strong level of evidence. Nevertheless, the csPCa yield for TBx alone versus TBx plus systematic bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Porreca, Angelo, Del Giudice, Francesco, Giampaoli, Marco, D’Agostino, Daniele, Romagnoli, Daniele, Corsi, Paolo, Del Rosso, Alessandro, Maggi, Martina, Chung, Benjamin I., Ferro, Matteo, de Cobelli, Ottavio, Lucarelli, Giuseppe, Schiavina, Riccardo, De Berardinis, Ettore, Sciarra, Alessandro, Busetto, Gian Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489582/
https://www.ncbi.nlm.nih.gov/pubmed/32925739
http://dx.doi.org/10.1097/MD.0000000000022059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489582/
https://www.ncbi.nlm.nih.gov/pubmed/32925739
http://dx.doi.org/10.1097/MD.0000000000022059

Ejemplares similares